// App-Quantinova.ai

19029 : The Sirt1 Activator, SRT1720, Attenuates Cardiac Hypertrophy and Fibrosis in a Rodent Pressure Overload Model

Researchers

Presenter

  • Robert A Civitarese

Principal Investigators

  • Antoinette Bugyei-Twum

  • Kim A Connelly

  • Melissa Mitchell

  • Jean-Francois Desjardins

  • Kerri Thai

  • Armin Abadeh

  • Yanling Zhang

  • Jennifer Switzer

  • Andrew Advani

  • Richard E Gilbert

Medical Centers

  • St. Michael's Hosp, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Hypertrophic cardiomyopathy

  • Cardiac fibrosis

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • SRT1720

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved